Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Canada Revokes Bevacizumab for Breast Cancer, But Not EuropeCanada Revokes Bevacizumab for Breast Ca
Link ID 38428
Title Canada Revokes Bevacizumab for Breast Cancer, But Not EuropeCanada Revokes Bevacizumab for Breast Ca
Url http://www.medscape.com/viewarticle/754373?src=rsshttp://www.medscape.com/viewarticle/754373?src=rss
Description Canada has followed the United States in revoking the metastatic breast cancer indication for bevacizumab, but it remains in place in Europe. News Alerts
Category Articles > Hematology-Oncology
Keywords
Date Nov 30, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. New Advances in the Treatment of Chronic Myelogenous Leukemia
  Review the development of imatinib resistance and management strategies for CML patients who develop resistance.
Category:   Articles > Hematology-Oncology


2. Solid Organ Transplantation in AL Amyloidosis
  AL amyloid can deposit in almost any organ with devastating consequences, but how viable is transplantation as a treatment alternative in this setting? American Journal of Transplantation
Category:   Articles > Hematology-Oncology


3. Abiraterone Acetate: a Promising Drug for the Treatment of Castration-Resistant Prostate Cancer
  This pregnenolone analog is an orally administered agent that irreversibly inhibits a rate-limiting enzyme in androgen biosysnthesis, and blocks the synthesis of androgens without causing adrenal insufficiency. Future Oncology
Category:   Articles > Hematology-Oncology


4. Use of Tumor Markers Low in Testis Cancer
  The use of tumor markers in testis cancer is low and varies considerably in the United States, despite the role markers can play in providing information pertinent to diagnosis, risk stratification, response to therapy, and disease recurrence. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Association Between Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and Persistent Activation
  LYN Kinase: Does inhibiting it create a clinical response in patients with chronic myelogenous leukemia?
Journal of the National Cancer Institute
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS